LEXX
Price:
$2.21
Market Cap:
$38.57M
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and in some instances with cannabinoids by 27x compared to standard industry formulations, reduce time of onset from 1 - 2 hours to minutes, and mask unwanted tastes; and is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (NSAIDs), PDE5 inhibitors, and others. DehydraTECH also deliver drugs effectiv...[Read more]
Industry
Biotechnology
IPO Date
2021-01-12
Stock Exchange
NASDAQ
Ticker
LEXX
According to Lexaria Bioscience Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 32.21M. This represents a change of 54.14% compared to the average of 20.89M of the last 4 quarters.
The mean historical Enterprise Value of Lexaria Bioscience Corp. over the last ten years is 12.49M. The current 32.21M Enterprise Value has changed 25.68% with respect to the historical average. Over the past ten years (40 quarters), LEXX's Enterprise Value was at its highest in in the May 2024 quarter at 45.58M. The Enterprise Value was at its lowest in in the August 2024 quarter at -6362519.00.
Average
12.49M
Median
9.60M
Minimum
5.67M
Maximum
42.06M
Discovering the peaks and valleys of Lexaria Bioscience Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 630.62%
Maximum Annual Enterprise Value = 42.06M
Minimum Annual Increase = -95.13%
Minimum Annual Enterprise Value = 5.67M
Year | Enterprise Value | Change |
---|---|---|
2024 | 42.06M | 630.62% |
2023 | 5.76M | -50.62% |
2022 | 11.66M | -29.33% |
2021 | 16.49M | 46.13% |
2020 | 11.29M | 9.25% |
2019 | 10.33M | 16.38% |
2018 | 8.88M | 41.25% |
2017 | 6.28M | -3.28% |
2016 | 6.50M | 14.64% |
2015 | 5.67M | -95.13% |
The current Enterprise Value of Lexaria Bioscience Corp. (LEXX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
19.82M
5-year avg
17.45M
10-year avg
12.49M
Lexaria Bioscience Corp.’s Enterprise Value is greater than Revelation Biosciences, Inc. (-4029924.00), greater than Zura Bio Limited (-36740010.00), greater than Phio Pharmaceuticals Corp. (-3068516.00), greater than ZyVersa Therapeutics, Inc. (2.57M), greater than TransCode Therapeutics, Inc. (727.36K), less than Immix Biopharma, Inc. (41.37M), greater than CNS Pharmaceuticals, Inc. (-675887.00), greater than eFFECTOR Therapeutics, Inc. (4.74M), greater than Navidea Biopharmaceuticals, Inc. (-2595051.00), greater than Sonnet BioTherapeutics Holdings, Inc. (4.25M), greater than SeaStar Medical Holding Corporation (6.98M), greater than Virios Therapeutics, Inc. (-2813681.00), less than Biodexa Pharmaceuticals Plc (0), less than Oncorus, Inc. (775.53M), less than null (42.71M),
Company | Enterprise Value | Market cap |
---|---|---|
-4029924.00 | $2.51M | |
-36740010.00 | $151.48M | |
-3068516.00 | $2.32M | |
2.57M | $2.70M | |
727.36K | $2.45M | |
41.37M | $59.97M | |
-675887.00 | $6.27M | |
4.74M | $941.00 | |
-2595051.00 | $10.01K | |
4.25M | $4.27M | |
6.98M | $9.06M | |
-2813681.00 | $206.50K | |
0 | $996.56M | |
775.53M | $0 | |
42.71M | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lexaria Bioscience Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lexaria Bioscience Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Lexaria Bioscience Corp.'s Enterprise Value?
What is the highest Enterprise Value for Lexaria Bioscience Corp. (LEXX)?
What is the 3-year average Enterprise Value for Lexaria Bioscience Corp. (LEXX)?
What is the 5-year average Enterprise Value for Lexaria Bioscience Corp. (LEXX)?
How does the current Enterprise Value for Lexaria Bioscience Corp. (LEXX) compare to its historical average?